We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Creo Medical Group Plc | LSE:CREO | London | Ordinary Share | GB00BZ1BLL44 | ORD GBP0.001 |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.50 | -1.40% | 35.25 | 35.00 | 35.50 | 35.75 | 35.25 | 35.75 | 197,799 | 10:14:20 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Surgical,med Instr,apparatus | 27.17M | -26.94M | -0.0746 | -4.73 | 127.34M |
Date | Subject | Author | Discuss |
---|---|---|---|
05/4/2018 10:09 | Hitting new highs again. | someuwin | |
20/3/2018 17:42 | A confident and reassuringly positive update on current progress. The product is clearly a game-changer, but as I read it there will be no cash coming through the door for at least another 12-18 months. After that this could be quite an earner. Happy to stick around and see how it pans out - and indeed to top up on the inevitable drops in the share price | lurki0 | |
20/3/2018 11:27 | I guess the pullback today is because there was no blockbuster news about contracts or juicy new info about products? Or that full product rollout is not until 2019 maybe. I'm holding, this seems to be well run and on track, much better than some other AIM companies! | dplewis1 | |
09/3/2018 12:29 | Difficult to get hold of meaningful amounts. I am surmising that the positive interest here is connected with an expectation of good news from the US re a ramping up of a Speedboat RS2 launch. | lurki0 | |
09/3/2018 08:20 | More buyers than sellers.. | dplewis1 | |
08/3/2018 13:30 | wot is going on here? | gersemi | |
08/3/2018 13:07 | Blimey on an absolute tear now | dplewis1 | |
08/3/2018 10:33 | Certainly sounds like there's massive potential here... Craig Gulliford, Chief Executive Officer of Creo Medical, commented: "We are excited by today's announcement as it provides further validation of our technology. It is incredible that these patients were conscious, talking to the endoscopist and able to watch the procedure live on screen. While we need to collect additional supportive clinical data, we are encouraged by the results we've seen to date. We believe that procedures like this have the potential to eliminate the need for subsequent bowel surgery, with the obvious patient benefits aligned with material advantages to the healthcare system in terms of cost and patient safety." | someuwin | |
08/3/2018 09:11 | Very perky. Let's hope these buys are "well-timed". | lurki0 | |
08/3/2018 08:28 | When I bought these a few months ago I had them down as a slow burner, it's now one of my best performers! | dplewis1 | |
08/3/2018 08:23 | Can't even buy £2k online. | someuwin | |
07/3/2018 17:18 | Buy above the ask just before the close, really not many of these about! | dplewis1 | |
07/3/2018 14:27 | Tightly held, you see. That's what's causing the spikes. Could well be some sort of leak. Fascinating to see how this pans out in the short term. | lurki0 | |
05/3/2018 15:03 | Over a quid..leaky leaky | dplewis1 | |
05/3/2018 14:56 | Ticks up on almost every buy. | someuwin | |
05/3/2018 09:24 | This has gone up in a straight line since the end of Feb, but only a few percent a day so it stays under the radar. Feels like it won't be too long before the suspense is lifted and we find out some good news.. | dplewis1 | |
02/3/2018 14:28 | Just such low volumes though. If it's a leak they aren't exactly going to make millions off the back of it! Not that I'm complaining I picked up mine in the low 70's, but I think this is just PIs picking up a few off the back of CREO being at the Growth and Innovation forum a few weeks back | dplewis1 | |
02/3/2018 11:21 | Got a few of these on the back burner. Rather abruptly I find myself in profit! That's quite a spike over the last few days, which leads me to wonder whether it's a)positioning before the interims at the end of March, or b)there's good news in the pipeline. Any ideas, anyone? | lurki0 | |
01/3/2018 21:15 | And long may it continue! | sh0wmethemoney | |
27/2/2018 12:39 | Ticking up slowly but surely here over the past couple of months.. | dplewis1 | |
09/2/2018 08:26 | Seems like a sensible approach. I guess as people get older and fatter there will be much more need for GI surgery and this CROMA method seems to be the safest of the lot. | dplewis1 | |
08/2/2018 22:20 | Yeh, have a few tucked away in the Sipp so hoping that in the net 15-20 years they are worth a good bit more than today ? | sh0wmethemoney | |
08/2/2018 11:11 | Doesn't take much to shift this does it! Anyone else following? They are quite sparing with the updates but looks to be going in the right direction.. | dplewis1 | |
29/11/2017 10:14 | RNS Number : 7877X Creo Medical Group PLC 29 November 2017 Speedboat RS2 advances beyond initial pilot centre Speedboat RS2 utilised at second NHS site Chepstow, South Wales - 29 November 2017 - Creo Medical Group plc (AIM: CREO) is pleased to announce that Speedboat RS2 has been used by a second Gastroenterologist at a second NHS site to treat further patients. This follows the announcement earlier this year with the first patient being treated at St Marks hospital in London. Initial feedback from the first two cases at this site confirmed the removal of lesions under local anaesthetic with a procedure time of under one hour. The patients were discharged on the same day and are now under routine follow-up and monitoring. We await final histology results. Craig Gulliford, Chief Executive Officer of Creo Medical, commented: "We are excited by today's announcement as it provides further validation of our technology. It is incredible that these patients were conscious, talking to the endoscopist and able to watch the procedure live on screen. While we need to collect additional supportive clinical data, we are encouraged by the results we've seen to date. We believe that procedures like this have the potential to eliminate the need for subsequent bowel surgery, with the obvious patient benefits aligned with material advantages to the healthcare system in terms of cost and patient safety." | pecuniarum copia | |
21/8/2017 10:02 | Good news on on the FDA approval ahead of schedule, will open the door to a big market ahead of the plan. Let the good news continue!!! | sh0wmethemoney |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions